Basalo, Cerilo C.
HRN: 26-38-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2025
CEFTAZIDIME 1GM (VIAL)
02/26/2025
03/04/2025
IV
500mg OD
Once Daily
CAPMR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes